Overview
Please click on Next tab to advance through activity.
As the standards of care for patients with myeloproliferative neoplasms (MPNs) continue to evolve, physicians must stay informed on current research and treatment methods. MPN Updates, a three-times-a-year digital publication, focuses on the diagnosis and treatment of MPN disease states and provides awareness of emerging therapeutic agents and their impact on patient outcomes.
This electronic newsletter is sponsored by Incyte Corp. through a third-party independent grant.
Click here to read past issues of MPN Updates.